Monthly Archives: December 2019
Pharmac reverses controversial brand switch decision
Pharmac has been placed in the spotlight over their decision earlier in the year to fund only one brand of anti-epileptic medication, lamotrigine, instead of the previously funded three lamotrigine brands. Prior to the switch, Medsafe warned Pharmac that the … Continue reading
Posted in Market Access
Tagged Market Access, New Zealand, Patient Safety, PHARMAC, Pharmaceuticals
Comments Off on Pharmac reverses controversial brand switch decision
